These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3833587)

  • 1. [Aztreonam in the treatment of bacterial infections in subjects with malignant blood diseases].
    Invernizzi R; Nastasi G; Mazzone A; Perseghin P; Michienzi M; Rizzo SC
    G Ital Chemioter; 1985; 32(2):453-7. PubMed ID: 3833587
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of infections during hematologic malignancies with aztreonam, a new antibiotic.
    Rizzo SC; Ricevuti G; Invernizzi R; Mazzone A; Nastasi G
    Chemioterapia; 1986 Dec; 5(6):400-3. PubMed ID: 3802302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aztreonam in infections caused by gram-negative aerobic bacilli].
    Rodríguez French A; Kenion G; Rodríguez C
    Rev Med Panama; 1988 Jan; 13(1):4-8. PubMed ID: 3347772
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of aztreonam in the treatment of acute and flare-ups of chronic infectious bronchopneumopathies].
    Aquino G; Barbera S; Romano F; Zottola V
    Clin Ter; 1988 Jan; 124(2):109-16. PubMed ID: 2973921
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic effectiveness of aztreonam on severe infections associated with hematologic disorders. Hanshin Infection Study Group].
    Hirayama F; Masaoka T; Shibata H; Nagai K; Kitani T; Horiuchi A; Kawagoe H; Yasunaga K; Okamoto Y; Yonezawa T
    Jpn J Antibiot; 1985 Sep; 38(9):2402-12. PubMed ID: 4079014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the clinical effectiveness of aztreonam in gram-negative infections of the biliary tract].
    Pedretti G; Magnani G
    G Ital Chemioter; 1988; 35(1-3):45-8. PubMed ID: 3256512
    [No Abstract]   [Full Text] [Related]  

  • 7. [An Italian multicenter study on the efficacy and tolerability of aztreonam in the treatment of urinary tract infections].
    Martelli A; Cortecchia V; Ventriglia L
    Clin Ter; 1988 May; 125(3):191-201. PubMed ID: 2973940
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aztreonam in severe gram-negative infections in hospitalized patients. Clinical experience in Spain. Preliminary data].
    García-Rodríguez JA; Rabinad E
    Med Clin (Barc); 1987 Apr; 88(13):538-43. PubMed ID: 3586736
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sepsis in hematologic diseases].
    Bláha M; Vanásek J; Splino M; Mĕrka V; Jebavý L; Lonská V; Siroký O; Pecka M
    Vnitr Lek; 1986 Nov; 32(11):1044-50. PubMed ID: 3798770
    [No Abstract]   [Full Text] [Related]  

  • 10. Aztreonam for severe infections.
    Wood MJ; Smith G; Farrell ID
    Chemioterapia; 1987 Jun; 6(2 Suppl):384-5. PubMed ID: 3509453
    [No Abstract]   [Full Text] [Related]  

  • 11. Aztreonam: early clinical studies in New Jersey.
    Johnson ES; Eng RK; Perez EM; Smith LG
    N J Med; 1986 Jan; Spec No():26-9. PubMed ID: 3513061
    [No Abstract]   [Full Text] [Related]  

  • 12. Netilmicin therapy of patients with leukaemia or malignant lymphoma.
    Geisler C; Hansen MM; Mortensen N; Traun-Pedersen P
    Scand J Infect Dis Suppl; 1980; Suppl 23():176-80. PubMed ID: 6937964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infections in leukemia and malignant lymphoma. Comparison between 2 antibiotic regimens: amikacin or gentamicin in combination with cephalothin].
    Jastrup B; Sørensen IG; Lomholt P; Vad NK
    Ugeskr Laeger; 1981 May; 143(20):1262-7. PubMed ID: 7292683
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cefotiam in infections of granulocytopenic tumor patients].
    Spors S; Seng P; Nossek L
    Med Welt; 1982 Dec; 33(48):1749-50. PubMed ID: 6296600
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment with aztreonam of gram negative infections in patients seropositive for HIV].
    Catania S; Mascellino MT; Trinchieri V; Musso R; Lorenzi A; Cirelli A
    Riv Eur Sci Med Farmacol; 1988 Aug; 10(4):317-21. PubMed ID: 3274906
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of infections in granulocytopenia patients with a brulamycin-bactrim combination].
    Magyar T; Graber H; Arr M; Csiba A; Kelemen E; Péterfy M; Jánossa M
    Orv Hetil; 1985 Sep; 126(35):2165-8. PubMed ID: 3875821
    [No Abstract]   [Full Text] [Related]  

  • 17. [Infections during the treatment of leukemia or malignant lymphoma].
    Tatsumi N; Masaoka T; Yoshitake J; Hasegawa Y; Ueda Y
    Rinsho Ketsueki; 1973 Feb; 14(2):136-41. PubMed ID: 4196636
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of azthreonam in the treatment of severe infections: study of 17 cases].
    León de Lope M; Nogales Pérez MC; Gálvez Acebal J; Mañas Frías R; Perea Pérez EJ; Martínez-Luengas F
    Med Clin (Barc); 1985 Jun; 85(2):58-60. PubMed ID: 4040593
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the therapeutic effects of aztreonam and ceftazidime in the treatment of complicated infections of the urinary tract].
    Orani A; Sala A; Spandri A; Levi L; Invernizzi S; Malagola G
    G Ital Chemioter; 1985; 32(2):443-7. PubMed ID: 3914433
    [No Abstract]   [Full Text] [Related]  

  • 20. [New beta-lactam antibiotics: penems and monobactams].
    Swierzy H
    Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1687-90. PubMed ID: 3268823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.